Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APPSwe/PS1ΔE9 Transgenic Female Mice

Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APPSwe/PS1ΔE9 Transgenic Female Mice

Alzheimer’s disease (AD) is a neurodegenerative disease that causes behavioral and cognitive impairments. The phytocannabinoid cannabidiol (CBD) has anti-inflammatory, antioxidant, and neuroprotective properties, and in vitro and limited in vivo evidence suggests that CBD possesses therapeutic-like...

Full description

Bibliographic Details
Main Authors:	Madilyn Coles, Georgia Watt, Fabian Kreilaus, Tim Karl
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-12-01
Series:	Frontiers in Pharmacology
Subjects:	Alzheimer’s disease APPSwe/PS1ΔE9 transgenic mouse model cannabidiol treatment behavior
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2020.587604/full

Similar Items

Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice
by: Eva Machová, et al.
Published: (2010-04-01)

Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
by: Monica Garcia-Alloza, et al.
Published: (2006-12-01)

DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice
by: C.R. Hooijmans, et al.
Published: (2009-03-01)

The Cyanthin Diterpenoid and Sesterterpene Constituents of Hericium erinaceus Mycelium Ameliorate Alzheimer’s Disease-Related Pathologies in APP/PS1 Transgenic Mice
by: Tsai-Teng Tzeng, et al.
Published: (2018-02-01)

Age-related disturbances in DNA (hydroxy)methylation in APP/PS1 mice
by: Chouliaras Leonidas, et al.
Published: (2018-12-01)

Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice
by: Miren Ettcheto, et al.
Published: (2021-07-01)

Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways
by: Miren Ettcheto, et al.
Published: (2017-10-01)

Analysis of Cannabidiol, Δ9-Tetrahydrocannabinol, and Their Acids in CBD Oil/Hemp Oil Products
by: Mahmoud A. ElSohly, et al.
Published: (2020-08-01)

Efficacy of Δ9 -Tetrahydrocannabinol (THC) Alone or in Combination With a 1:1 Ratio of Cannabidiol (CBD) in Reversing the Spatial Learning Deficits in Old Mice
by: Prakash Nidadavolu, et al.
Published: (2021-08-01)

Unraveling Early Signs of Navigational Impairment in APPswe/PS1dE9 Mice Using Morris Water Maze
by: Smitha Karunakaran
Published: (2020-12-01)

Long-Term Caloric Restriction Attenuates β-Amyloid Neuropathology and Is Accompanied by Autophagy in APPswe/PS1delta9 Mice
by: Luisa Müller, et al.
Published: (2021-03-01)

Cholinergic forebrain degeneration in the APPswe/PS1ΔE9 transgenic mouse
by: Sylvia E. Perez, et al.
Published: (2007-10-01)

Effector function of anti-pyroglutamate-3 Aβ antibodies affects cognitive benefit, glial activation and amyloid clearance in Alzheimer’s-like mice
by: Helen Crehan, et al.
Published: (2020-01-01)

Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review
by: Francesco Bartoli, et al.
Published: (2021-03-01)

Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract
by: Joseph J. Wakshlag, et al.
Published: (2020-09-01)

Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer’s disease mouse models
by: Khaled S. Abd-Elrahman, et al.
Published: (2018-04-01)

YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2
by: Zheng-Yi Li, et al.
Published: (2017-04-01)

Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study
by: Richard J. Huntsman, et al.
Published: (2019-07-01)

β-Asarone Attenuates Aβ-Induced Neuronal Damage in PC12 Cells Overexpressing APPswe by Restoring Autophagic Flux
by: Zhenwan Li, et al.
Published: (2021-07-01)

Effects of (-)epicatechin on the pathology of APP/PS1 transgenic mice
by: Yueqin eZeng, et al.
Published: (2014-05-01)

Naringin Enhances CaMKII Activity and Improves Long-Term Memory in a Mouse Model of Alzheimer’s Disease
by: Lian-Feng Zhang, et al.
Published: (2013-03-01)

Gastrodin as a multi-target protective compound reverses learning memory deficits and AD-like pathology in APP/PS1 transgenic mice
by: Yue-Qin Zeng, et al.
Published: (2021-02-01)

Impact de l’infection à Helicobacter pylori sur la maladie d’Alzheimer
by: Baudron Roubaud, Claire
Published: (2014)

Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer’s disease model
by: Parikh A, et al.
Published: (2018-07-01)

Beneficial effects of quetiapine in the APP/PS1 transgenic mice: implications for early intervention for Alzheimer's disease
by: Zhu, Shenghua
Published: (2011)

Beneficial effects of quetiapine in the APP/PS1 transgenic mice: implications for early intervention for Alzheimer's disease
by: Zhu, Shenghua
Published: (2011)

Δ 9-Tetrahydrocannabinol Toxicity and Validation of Cannabidiol on Brain Dopamine Levels: An Assessment on Cannabis Duplicity
by: Swapnali Chetia, et al.
Published: (2020-08-01)

Amelioration of Behavioral Impairments and Neuropathology by Antiepileptic Drug Topiramate in a Transgenic Alzheimer’s Disease Model Mice, APP/PS1
by: Brice Ayissi Owona, et al.
Published: (2019-06-01)

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
by: Paula Morales, et al.
Published: (2017-06-01)

Phosphorylation of Tau at S422 is enhanced by Aβ in TauPS2APP triple transgenic mice
by: Fiona Grueninger, et al.
Published: (2010-02-01)

Epilepsy and cannabidiol - a new perspective for seizures treatment
by: Ilona Kozioł, et al.
Published: (2021-08-01)

The content of basic cannabinoids and their mutual ratios in Cannabis sativa L. plant
by: Dragoljić Mirjana M., et al.
Published: (2019-01-01)

Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis
by: Ana Pilar Pérez-Acevedo, et al.
Published: (2020-12-01)

Antioxidative and Anti-Inflammatory Properties of Cannabidiol
by: Sinemyiz Atalay, et al.
Published: (2019-12-01)

Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects
by: Christopher S. Pauli, et al.
Published: (2020-02-01)

YXQN Reduces Alzheimer’s Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice
by: Xiaowan Wang, et al.
Published: (2017-05-01)

N-linoleyltyrosine exerts neuroprotective effects in APP/PS1 transgenic mice via cannabinoid receptor-mediated autophagy
by: Chun-mei Long, et al.
Published: (2021-12-01)

Running exercise reduces dendritic spine loss in medial prefrontal cortex of double transgenic APP/PS1 mice
by: FAN Jinhua, et al.
Published: (2019-07-01)

Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from <i>Cannabis sativa</i> L
by: Laura Daniela Martinenghi, et al.
Published: (2020-06-01)

CONSIDERATIONS ON THE CANNABIDIOL IN THE PSYCHOTHERAPY PROCESS OF CHILDREN WITH AUTISTIC SPECTRUM DISORDER
by: Allana Daiara Correia Oliveira, et al.
Published: (2019-12-01)